A cardioprotective analgesic for acute MI?
Cutting-edge science and differentiation
Previously-unknown relationships are revealed by McCormack’s initial CEME probe. This is then followed with a new analysis by McCormack which suggests the novel prospect of cardioprotective effects of buprenorphine in patients with acute MI.
Clinical implications of new teachings
These new findings suggest that buprenorphine may be the opioid of choice in managing the pain of MI.
- Expansion of use within an approved indication
- Prospect of a new indication as a cardioprotective agent
- Prospect of new IP within a new indication
Published new teachings
- McCormack K, Chapleo C. ‘Opioid Receptors and Myocardial Protection: Do some opioid agonists possess cardioprotective effects?’. Clinical Drug Investigation, 1998 15(5) 445-454.